Literature DB >> 2839170

Synthesis of a new cell penetrating calpain inhibitor (calpeptin).

T Tsujinaka1, Y Kajiwara, J Kambayashi, M Sakon, N Higuchi, T Tanaka, T Mori.   

Abstract

N-terminal of Leu-norleucinal or Leu-methioninal was modified to obtain a cell penetrative peptide inhibitor against calpain. Benzyloxycarbonyl (Z) derivatives had less active against papain than phenylbutyryl derivatives and leupeptin. Z-Leu-nLeu-H (calpeptin) was more sensitive to calpain I than Z-Leu-Met-H and leupeptin. Calpeptin was most potent among synthesized inhibitors in terms of preventing the Ca2+-ionophore induced degradation of actin binding protein and P235 in intact platelets. After 30 min incubation with intact platelets, calpeptin completely abolished calpain activity in platelets but no effect was observed in case of leupeptin. Calpeptin also inhibited 20K phosphorylation in platelets stimulated by thrombin, ionomycin or collagen. Thus calpeptin was found to be a useful cell-penetrative calpain inhibitor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839170     DOI: 10.1016/s0006-291x(88)81355-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  51 in total

1.  Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Authors:  J C Reverter; S Béguin; H Kessels; R Kumar; H C Hemker; B S Coller
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Non-muscle myosin IIA differentially regulates intestinal epithelial cell restitution and matrix invasion.

Authors:  Brian A Babbin; Stefan Koch; Moshe Bachar; Mary-Anne Conti; Charles A Parkos; Robert S Adelstein; Asma Nusrat; Andrei I Ivanov
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

4.  Internal deletions of IE2 86 and loss of the late IE2 60 and IE2 40 proteins encoded by human cytomegalovirus affect the levels of UL84 protein but not the amount of UL84 mRNA or the loading and distribution of the mRNA on polysomes.

Authors:  Rebecca L Sanders; Christia J Del Rosario; Elizabeth A White; Deborah H Spector
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

5.  Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis.

Authors:  M Kelly Guyton; Arabinda Das; Supriti Samantaray; Gerald C Wallace; Jonathan T Butler; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2010-08-15       Impact factor: 4.164

6.  Identification and optimization of a novel inhibitor of mitochondrial calpain 10.

Authors:  Kyle A Rasbach; David D Arrington; Sina Odejinmi; Chris Giguere; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

7.  Calcium-activated proteases are critical for refilling depleted vesicle stores in cultured sensory-motor synapses of Aplysia.

Authors:  Arkady Khoutorsky; Micha E Spira
Journal:  Learn Mem       Date:  2005 Jul-Aug       Impact factor: 2.460

8.  Calpain-Inhibitors Protect Frataxin-Deficient Dorsal Root Ganglia Neurons from Loss of Mitochondrial Na+/Ca2+ Exchanger, NCLX, and Apoptosis.

Authors:  Elena Britti; Fabien Delaspre; Jordi Tamarit; Joaquim Ros
Journal:  Neurochem Res       Date:  2020-04-06       Impact factor: 3.996

9.  Limitations of SLLVY-AMC in calpain and proteasome measurements.

Authors:  Christopher J Giguere; Rick G Schnellmann
Journal:  Biochem Biophys Res Commun       Date:  2008-05-05       Impact factor: 3.575

10.  The role of elevations in intracellular [Ca2+] in the development of low frequency fatigue in mouse single muscle fibres.

Authors:  E R Chin; D G Allen
Journal:  J Physiol       Date:  1996-03-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.